This commentary, published in The Lancet Diabetes & Endocrinology, outlines the imperative to extend global research, access to medicines, and care delivery efforts to better address the diabetes burden of the world’s poorest patients. The article also announces two current initiatives supported by Helmsley Charitable Trust, including PIH’s efforts to improve integrated diabetes care in Haiti and Rwanda.